HMA - Heads of Medicines Agencies
  • RSS
  • Sitemap
  • Login (HMA-DMS)
  • Contact
  • About HMA
  • Human Medicines
  • Veterinary Medicines
  • You are here:
  • Home
  • >Human Medicines
  • >CMDh
  • >Procedural Guidance
  • >Renewal
  • CMDh
    • About CMDh
    • Statistics
    • Agendas and Minutes
    • Press Releases
    • COVID-19
    • BREXIT
    • Procedural Guidance
      • General Info
      • Application for MA
      • eSubmissions
      • Generics
      • Applicant´s Responses
      • Renewal
      • Consultation with target patient groups
      • Variation
      • USR
      • Art 61.3 Procedure
      • Post Referral Phase
    • CMDh-Referrals
    • Product Information
    • Advice from CMDh
    • Templates
    • CMD Working Parties / Working Groups
    • Paediatric Regulation
    • Pharmacovigilance
    • Falsified Medicines
    • Questions & Answers
    • Contact Points
    • Recently Published history
  • MRI Product Index
  • Pharmacovigilance
  • Availability of Medicines
  • Publications and reports
  • National Contacts

 

Renewal Procedure

In order to view some of the documents on this website you need Acrobat Reader
(click here to download)

  • CMDh Best Practice Guide on the processing of renewals in the MRP/DCP (November 2020) [Track version]
  • Common grounds seen for delaying Day 0 Renewals(July 2017) [Track version]
  • Data requested for Variations and/or Renewal Applications in the MRP/DCP
  • Requirements on submissions for Variations and Renewals within MRP and National Procedures
  • Languages to be used for Marketing Authorisation Application (MAA), Variations and Renewals
  • Mock-ups, Specimens and Samples for variations and renewals
  • Member State agreement upon conditions under which the RMS can start renewal procedures (July 2017) [Track version]

The United Kingdom (UK) withdrew from the European Union (EU) on 31 January 2020 and is no longer an EU Member State. HMA and CMDh/v are in the process of making appropriate changes to this website. If the site still contains content that does not yet reflect the withdrawal of the UK from the EU, this is unintentional and will be addressed. In case you notice information that should be updated, please report this website link using the contact form.

  • Useful Links
  • Privacy Policy
  • Credits & Disclaimer
  • Contact
© Heads of Medicines Agencies - https://www.hma.eu/human-medicines/cmdh/procedural-guidance/renewal.html